By binding to the processor protein DGCR8 and favorably controlling the pri-miR222/6 pathway in a m221A-dependent manner, METTL3 (methyltransferase-like 3) may play an oncogenic function in bladder cancer (Han et al. 2019). The gene discussed is DGCR8; the disease is urinary bladder cancer.